DOAC renal monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Renal function should be reviewed to confirm the dose remains appropriate
Renal function affects rivaroxaban exposure and dose suitability. A fall in eGFR may require dose review or reconsideration of anticoagulant choice depending on indication and local guidance. INR monitoring does not measure rivaroxaban anticoagulant effect for routine care. The pharmacist should prompt prescriber review rather than ignore the renal change.
Reference: BNF; NICE CKS